MeSH Tree Structures - 2015

N05 - Health Care Quality, Access, and Evaluation

• Health Care Quality, Access, and Evaluation [N05]
  • Delivery of Health Care [N05.300]
    • After-Hours Care [N05.300.049]
      • Answering Services [N05.300.049.500]
    • Attitude of Health Personnel [N05.300.100]
      • Nurse's Role [N05.300.100.337]
      • Refusal to Treat [N05.300.100.675]
    • Attitude to Death [N05.300.125]
    • Attitude to Health [N05.300.150]
      • Health Services Misuse [N05.300.150.395]
        • Unnecessary Procedures [N05.300.150.395.900]
      • Health Knowledge, Attitudes, Practice [N05.300.150.410]
      • Patient Acceptance of Health Care [N05.300.150.600]
        • Patient Compliance [N05.300.150.600.600]
          • Medication Adherence [N05.300.150.600.600.500]
        • Patient Participation [N05.300.150.600.620]
        • Patient Satisfaction [N05.300.150.600.630]
          • Patient Preference [N05.300.150.600.630.500]
        • Treatment Refusal [N05.300.150.600.800]
    • Culturally Competent Care [N05.300.206]
    • Delivery of Health Care, Integrated [N05.300.262]
      • Provider-Sponsored Organizations [N05.300.262.600]
    • Dentist's Practice Patterns [N05.300.300]
    • Health Care Costs [N05.300.375]
      • Direct Service Costs [N05.300.375.250]
      • Drug Costs [N05.300.375.300]
      • Employer Health Costs [N05.300.375.350]
      • Hospital Costs [N05.300.375.500]
    • Health Care Reform [N05.300.380]
      • Accountable Care Organizations [N05.300.380.500]
    • Health Expenditures [N05.300.385]
    • Health Priorities [N05.300.400]
    • Health Resources [N05.300.420]
      • Health Manpower [N05.300.420.400]
      • Strategic Stockpile [N05.300.420.700]
    • Health Services Accessibility [N05.300.430]
      • Health Care Rationing [N05.300.430.375]
      • Health Facility Closure [N05.300.430.390]
      • Health Facility Environment [N05.300.430.400]
      • Health Facility Size [N05.300.430.410]
      • Marketing of Health Services [N05.300.430.500]
        • Social Marketing [N05.300.430.500.500]
    • Health Services Needs and Demand [N05.300.450]
      • Medically Underserved Area [N05.300.450.520]
      • Surge Capacity [N05.300.450.760]
    • Healthcare Disparities [N05.300.493]
    • Medical Tourism [N05.300.515]
    • Needs Assessment [N05.300.537]
    • Nurse's Practice Patterns [N05.300.581]
    • Physician's Practice Patterns [N05.300.625]
    • Professional-Patient Relations [N05.300.660]
      • Dentist-Patient Relations [N05.300.660.325]
      • Nurse-Patient Relations [N05.300.660.560]
      • Physician-Patient Relations [N05.300.660.625]
    • Secondary Care [N05.300.745]
    • Tertiary Healthcare [N05.300.787]
    • Uncompensated Care [N05.300.830]
  • Ethics [N05.350]
    • Bioethics [N05.350.200]
      • Ethics, Clinical [N05.350.200.500]
    • Conflict of Interest [N05.350.225]
      • Physician Self-Referral [N05.350.225.500]
    • Ethical Review [N05.350.250]
      • Ethics Consultation [N05.350.250.200]
    • Ethicists [N05.350.262]
    • Ethics Committees [N05.350.268]
      • Ethics Committees, Clinical [N05.350.268.500]
      • Ethics Committees, Research [N05.350.268.750]
    • Ethics, Institutional [N05.350.325]
    • Ethics, Professional [N05.350.340]
      • Codes of Ethics [N05.350.340.080]
        • Helsinki Declaration [N05.350.340.080.249]
        • Hippocratic Oath [N05.350.340.080.400]
      • Ethics, Clinical [N05.350.340.162]
        • Ethics, Dental [N05.350.340.162.249]
        • Ethics, Medical [N05.350.340.162.500]
        • Ethics, Nursing [N05.350.340.162.750]
        • Ethics, Pharmacy [N05.350.340.162.875]
    • Ethics, Research [N05.350.670]
  • Health Services Research [N05.425]
    • Community-Based Participatory Research [N05.425.104]
    • Comparative Effectiveness Research [N05.425.157]
    • Health Care Surveys [N05.425.210]
  • Quality Assurance, Health Care [N05.700]
    • Benchmarking [N05.700.150]
    • Clinical Audit [N05.700.175]
      • Dental Audit [N05.700.175.250]
      • Medical Audit [N05.700.175.500]
        • Commission on Professional and Hospital Activities [N05.700.175.500.200]
      • Nursing Audit [N05.700.175.520]
    • Credentialing [N05.700.200]
      • Accreditation [N05.700.200.100]
        • Joint Commission on Accreditation of Healthcare Organizations [N05.700.200.100.420]
      • Certification [N05.700.200.190]
        • Specialty Boards [N05.700.200.190.750]
      • Licensure [N05.700.200.450]
        • Licensure, Dental [N05.700.200.450.300]
        • Licensure, Hospital [N05.700.200.450.380]
        • Licensure, Medical [N05.700.200.450.500]
        • Licensure, Nursing [N05.700.200.450.550]
        • Licensure, Pharmacy [N05.700.200.450.625]
    • Facility Regulation and Control [N05.700.300]
    • Guidelines as Topic [N05.700.350]
      • Codes of Ethics [N05.700.350.324]
      • Practice Guidelines as Topic [N05.700.350.650]
    • Professional Review Organizations [N05.700.675]
    • Professional Staff Committees [N05.700.685]
      • Clinical Trials Data Monitoring Committees [N05.700.685.149]
      • Ethics Committees [N05.700.685.300]
        • Ethics Committees, Clinical [N05.700.685.300.500]
        • Ethics Committees, Research [N05.700.685.300.750]
      • Pharmacy and Therapeutics Committee [N05.700.685.625]
    • Total Quality Management [N05.700.792]
    • Utilization Review [N05.700.900]
      • Concurrent Review [N05.700.900.200]
      • Drug Utilization Review [N05.700.900.300]
  • Quality of Health Care [N05.715]
    • Epidemiologic Factors [N05.715.350]
      • Age Factors [N05.715.350.075]
        • Age of Onset [N05.715.350.075.100]
        • Maternal Age [N05.715.350.075.550]
      • Bias (Epidemiology) [N05.715.350.150]
        • Observer Variation [N05.715.350.150.675]
        • Selection Bias [N05.715.350.150.775]
      • Causality [N05.715.350.200]
        • Precipitating Factors [N05.715.350.200.650]
        • Protective Factors [N05.715.350.200.675]
        • Risk Factors [N05.715.350.200.700]
      • Comorbidity [N05.715.350.225]
      • Confounding Factors (Epidemiology) [N05.715.350.240]
      • Effect Modifier, Epidemiologic [N05.715.350.350]
        • Cohort Effect [N05.715.350.350.225]
        • Healthy Worker Effect [N05.715.350.350.375]
        • Placebo Effect [N05.715.350.350.625]
          • Nocebo Effect [N05.715.350.350.625.500]
      • Reproductive History [N05.715.350.575]
      • Sex Factors [N05.715.350.675]
    • Health Care Evaluation Mechanisms [N05.715.360]
      • Data Collection [N05.715.360.300]
        • Checklist [N05.715.360.300.179]
        • Datasets as Topic [N05.715.360.300.224]
        • Focus Groups [N05.715.360.300.269]
        • Geriatric Assessment [N05.715.360.300.360]
        • Health Surveys [N05.715.360.300.375]
          • Behavioral Risk Factor Surveillance System [N05.715.360.300.375.149]
          • Dental Health Surveys [N05.715.360.300.375.300]
            • Dental Plaque Index [N05.715.360.300.375.300.325]
            • DMF Index [N05.715.360.300.375.300.340]
            • Index of Orthodontic Treatment Need [N05.715.360.300.375.300.505]
            • Oral Hygiene Index [N05.715.360.300.375.300.670]
            • Periodontal Index [N05.715.360.300.375.300.690]
          • Health Status Indicators [N05.715.360.300.375.375]
            • Organ Dysfunction Scores [N05.715.360.300.375.375.181]
            • Patient Acuity [N05.715.360.300.375.375.364]
              • Severity of Illness Index [N05.715.360.300.375.375.364.500]
                • Karnofsky Performance Status [N05.715.360.300.375.375.364.500.500]
            • Sickness Impact Profile [N05.715.360.300.375.375.730]
          • Mass Screening [N05.715.360.300.375.500]
            • Anonymous Testing [N05.715.360.300.375.500.174]
            • Mass Chest X-Ray [N05.715.360.300.375.500.500]
            • Multiphasic Screening [N05.715.360.300.375.500.540]
            • Neonatal Screening [N05.715.360.300.375.500.575]
            • Vision Screening [N05.715.360.300.375.500.825]
          • Nutrition Surveys [N05.715.360.300.375.560]
            • Diet Surveys [N05.715.360.300.375.560.300]
          • Population Surveillance [N05.715.360.300.375.625]
            • Public Health Surveillance [N05.715.360.300.375.625.324]
            • Sentinel Surveillance [N05.715.360.300.375.625.650]
        • Health Care Surveys [N05.715.360.300.387]
        • Interviews as Topic [N05.715.360.300.400]
        • Narration [N05.715.360.300.480]
        • Nutrition Assessment [N05.715.360.300.560]
        • Nutrition Surveys [N05.715.360.300.627]
          • Diet Surveys [N05.715.360.300.627.300]
        • Questionnaires [N05.715.360.300.695]
          • Self Report [N05.715.360.300.695.500]
        • Records as Topic [N05.715.360.300.715]
          • Birth Certificates [N05.715.360.300.715.175]
          • Consent Forms [N05.715.360.300.715.245]
          • Death Certificates [N05.715.360.300.715.315]
          • Dental Records [N05.715.360.300.715.330]
          • Hospital Records [N05.715.360.300.715.380]
          • Medical Records [N05.715.360.300.715.500]
            • Clinical Coding [N05.715.360.300.715.500.249]
            • Medical Record Linkage [N05.715.360.300.715.500.500]
            • Medical Records, Problem-Oriented [N05.715.360.300.715.500.520]
            • Medical Records Systems, Computerized [N05.715.360.300.715.500.530]
            • Patient Discharge Summaries [N05.715.360.300.715.500.665]
            • Trauma Severity Indices [N05.715.360.300.715.500.800]
              • Abbreviated Injury Scale [N05.715.360.300.715.500.800.100]
              • Glasgow Coma Scale [N05.715.360.300.715.500.800.325]
              • Glasgow Outcome Scale [N05.715.360.300.715.500.800.335]
              • Injury Severity Score [N05.715.360.300.715.500.800.400]
          • Nursing Records [N05.715.360.300.715.550]
          • Registries [N05.715.360.300.715.700]
            • SEER Program [N05.715.360.300.715.700.725]
      • Advance Directive Adherence [N05.715.360.317]
      • Evaluation Studies as Topic [N05.715.360.335]
        • Validation Studies as Topic [N05.715.360.335.500]
      • Guideline Adherence [N05.715.360.395]
      • Organizational Case Studies [N05.715.360.455]
      • Outcome and Process Assessment (Health Care) [N05.715.360.575]
        • Outcome Assessment (Health Care) [N05.715.360.575.575]
          • Patient Outcome Assessment [N05.715.360.575.575.399]
            • Lysholm Knee Score [N05.715.360.575.575.399.500]
          • Treatment Outcome [N05.715.360.575.575.800]
            • Early Termination of Clinical Trials [N05.715.360.575.575.800.379]
            • Response Evaluation Criteria in Solid Tumors [N05.715.360.575.575.800.569]
            • Treatment Failure [N05.715.360.575.575.800.760]
        • Process Assessment (Health Care) [N05.715.360.575.625]
      • Patient Satisfaction [N05.715.360.600]
      • Program Evaluation [N05.715.360.650]
        • Benchmarking [N05.715.360.650.150]
      • Root Cause Analysis [N05.715.360.700]
      • Statistics as Topic [N05.715.360.750]
        • Actuarial Analysis [N05.715.360.750.100]
        • Analysis of Variance [N05.715.360.750.125]
          • Multivariate Analysis [N05.715.360.750.125.500]
        • Cluster Analysis [N05.715.360.750.200]
          • Small-Area Analysis [N05.715.360.750.200.750]
          • Space-Time Clustering [N05.715.360.750.200.775]
        • Confidence Intervals [N05.715.360.750.220]
        • Data Interpretation, Statistical [N05.715.360.750.300]
        • Discriminant Analysis [N05.715.360.750.325]
        • Factor Analysis, Statistical [N05.715.360.750.350]
        • Matched-Pair Analysis [N05.715.360.750.500]
        • Models, Statistical [N05.715.360.750.530]
          • Likelihood Functions [N05.715.360.750.530.450]
          • Linear Models [N05.715.360.750.530.460]
          • Logistic Models [N05.715.360.750.530.480]
          • Models, Economic [N05.715.360.750.530.500]
            • Models, Econometric [N05.715.360.750.530.500.500]
          • Nomograms [N05.715.360.750.530.530]
          • Proportional Hazards Models [N05.715.360.750.530.650]
        • Monte Carlo Method [N05.715.360.750.540]
        • Probability [N05.715.360.750.625]
          • Bayes Theorem [N05.715.360.750.625.150]
          • Likelihood Functions [N05.715.360.750.625.450]
          • Markov Chains [N05.715.360.750.625.500]
          • Odds Ratio [N05.715.360.750.625.590]
          • Propensity Score [N05.715.360.750.625.620]
          • Proportional Hazards Models [N05.715.360.750.625.650]
          • Risk [N05.715.360.750.625.700]
            • Logistic Models [N05.715.360.750.625.700.450]
            • Protective Factors [N05.715.360.750.625.700.570]
            • Risk Assessment [N05.715.360.750.625.700.690]
              • Risk Adjustment [N05.715.360.750.625.700.690.800]
            • Risk Factors [N05.715.360.750.625.700.700]
          • Uncertainty [N05.715.360.750.625.850]
        • Regression Analysis [N05.715.360.750.695]
          • Least-Squares Analysis [N05.715.360.750.695.440]
          • Linear Models [N05.715.360.750.695.460]
          • Logistic Models [N05.715.360.750.695.470]
          • Proportional Hazards Models [N05.715.360.750.695.650]
        • Sensitivity and Specificity [N05.715.360.750.725]
          • Limit of Detection [N05.715.360.750.725.500]
          • Signal-To-Noise Ratio [N05.715.360.750.725.750]
        • Spatial Analysis [N05.715.360.750.746]
          • Geographic Mapping [N05.715.360.750.746.249]
          • Spatio-Temporal Analysis [N05.715.360.750.746.500]
        • Statistical Distributions [N05.715.360.750.750]
          • Binomial Distribution [N05.715.360.750.750.150]
          • Chi-Square Distribution [N05.715.360.750.750.200]
          • Normal Distribution [N05.715.360.750.750.565]
          • Poisson Distribution [N05.715.360.750.750.620]
        • Statistics, Nonparametric [N05.715.360.750.760]
        • Stochastic Processes [N05.715.360.750.770]
          • Markov Chains [N05.715.360.750.770.500]
        • Survival Analysis [N05.715.360.750.795]
          • Disease-Free Survival [N05.715.360.750.795.300]
          • Kaplan-Meier Estimate [N05.715.360.750.795.650]
          • Proportional Hazards Models [N05.715.360.750.795.825]
      • Epidemiologic Study Characteristics as Topic [N05.715.360.775]
        • Epidemiologic Studies [N05.715.360.775.175]
          • Case-Control Studies [N05.715.360.775.175.200]
            • Retrospective Studies [N05.715.360.775.175.200.710]
          • Cohort Studies [N05.715.360.775.175.250]
            • Follow-Up Studies [N05.715.360.775.175.250.350]
            • Longitudinal Studies [N05.715.360.775.175.250.450]
              • National Longitudinal Study of Adolescent Health [N05.715.360.775.175.250.450.500]
            • Prospective Studies [N05.715.360.775.175.250.630]
            • Retrospective Studies [N05.715.360.775.175.250.815]
          • Controlled Before-After Studies [N05.715.360.775.175.262]
          • Cross-Sectional Studies [N05.715.360.775.175.275]
          • Interrupted Time Series Analysis [N05.715.360.775.175.537]
          • Seroepidemiologic Studies [N05.715.360.775.175.800]
            • HIV Seroprevalence [N05.715.360.775.175.800.375]
        • Clinical Protocols [N05.715.360.775.225]
          • Antineoplastic Protocols [N05.715.360.775.225.500]
        • Clinical Trials as Topic [N05.715.360.775.235]
          • Clinical Trials, Phase I as Topic [N05.715.360.775.235.200]
          • Clinical Trials, Phase II as Topic [N05.715.360.775.235.210]
          • Clinical Trials, Phase III as Topic [N05.715.360.775.235.220]
          • Clinical Trials, Phase IV as Topic [N05.715.360.775.235.230]
          • Controlled Clinical Trials as Topic [N05.715.360.775.235.387]
            • Non-Randomized Controlled Trials as Topic [N05.715.360.775.235.387.249]
            • Randomized Controlled Trials as Topic [N05.715.360.775.235.387.500]
              • Intention to Treat Analysis [N05.715.360.775.235.387.500.500]
              • Pragmatic Clinical Trials as Topic [N05.715.360.775.235.387.500.750]
          • Multicenter Studies as Topic [N05.715.360.775.235.545]
        • Feasibility Studies [N05.715.360.775.350]
        • Intervention Studies [N05.715.360.775.390]
        • Pilot Projects [N05.715.360.775.625]
        • Sampling Studies [N05.715.360.775.700]
          • Lot Quality Assurance Sampling [N05.715.360.775.700.500]
        • Twin Studies as Topic [N05.715.360.775.750]
      • Epidemiologic Research Design [N05.715.360.780]
        • Cross-Over Studies [N05.715.360.780.150]
        • Double-Blind Method [N05.715.360.780.320]
        • Matched-Pair Analysis [N05.715.360.780.500]
        • Meta-Analysis as Topic [N05.715.360.780.515]
        • Random Allocation [N05.715.360.780.675]
        • Reproducibility of Results [N05.715.360.780.685]
          • Dimensional Measurement Accuracy [N05.715.360.780.685.500]
        • Sample Size [N05.715.360.780.692]
        • Sensitivity and Specificity [N05.715.360.780.700]
          • Predictive Value of Tests [N05.715.360.780.700.640]
          • ROC Curve [N05.715.360.780.700.680]
          • Signal-To-Noise Ratio [N05.715.360.780.700.840]
        • Single-Blind Method [N05.715.360.780.730]
      • Technology Assessment, Biomedical [N05.715.360.825]
    • Peer Review, Health Care [N05.715.680]
    • Standard of Care [N05.715.840]
      • Patient Handoff [N05.715.840.500]